FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RAXTOZINAMERAN
异名/同义词BNT162B2 OMICRON (XBB.1.5)
MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODON-OPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K982P AND V983P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) SPIKE (S) GLYCOPROTEIN (OMICRON SUB-LINEAGE XBB.1.5; BASED UPON GISAID:EPI_ISL_17157779), FLANKED BY 5' AND 3' UNTRANSLATED REGIONS AND A 3' POLYADENYLATION (POLYA) TAIL; CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M1.PSI.)
RAXTOZINAMERAN
RAXTOZINAMERAN [INN]
RAXTOZINAMERAN [WHO-DD]
RBP-020.2 4 (XBB.1.5 VARIANT)
RNA (RECOMBINANT 5'-(1,2-((3'-O-METHYL)M7G-(5'->5')-PPP-AM))-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN SECRETORY SIGNAL PEPTIDE PLUS CODON-OPTIMIZED PRE-FUSION SPIKE GLYCOPROTEIN OMICRON XBB.1.5 VARIANT (982-PROLINE,983-PROLINE)-SPECIFYING PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGERRBP020.2 4), INNER SALT
CAS登记号2887554-49-4
物质唯一标识(Unique Ingredient Identifier)N36VHK46PR
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System